Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
PUT
Middleby
MIDD
$6.03B
| $525K | ﹤0.01% |
4,100
+700
| +21% | +$86.3K |
|
|
HMSY
3527
DELISTED
HMS Holdings Corp.
HMSY
| $525K | ﹤0.01% |
26,437
-10,486
| -28% | -$195K |
|
|
PPL
3528
PUT
PPL Corp
PPL
$26B
| $524K | ﹤0.01% |
13,800
+5,500
| +66% | +$213K |
|
|
HK
3529
DELISTED
Halcon Resources Corporation
HK
| $524K | ﹤0.01% |
76,978
-35,296
| -31% | -$220K |
|
|
CVSA
3530
Covista Inc
CVSA
$4.23B
| $522K | ﹤0.01% |
14,539
+3,131
| +27% | +$107K |
|
3531
Pan American Silver
PAAS
$20.2B
| $522K | ﹤0.01% |
30,646
+3,051
| +11% | +$52.6K |
|
3532
RadNet
RDNT
$5.36B
| $522K | ﹤0.01% |
45,217
+12,688
| +39% | +$116K |
|
|
NRE
3533
DELISTED
NorthStar Realty Europe Corp.
NRE
| $522K | ﹤0.01% |
40,787
-2,386
| -6% | -$30.2K |
|
|
3534
PUT
Dover
DOV
$28.4B
| $521K | ﹤0.01% |
7,057
-69,575
| -91% | -$4.83M |
|
|
SGMO
3535
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $520K | ﹤0.01% |
34,655
+647
| +2% | +$7.15K |
|
3536
PUT
Gold Fields
GFI
$33.4B
| $519K | ﹤0.01% |
120,500
-22,500
| -16% | -$92.2K |
|
3537
National Health Investors
NHI
$3.65B
| $519K | ﹤0.01% |
6,718
+3,726
| +125% | +$291K |
|
|
PINC
3538
DELISTED
Premier
PINC
| $519K | ﹤0.01% |
15,933
+268
| +2% | +$9.09K |
|
|
BREW
3539
DELISTED
Craft Brew Alliance, Inc.
BREW
| $519K | ﹤0.01% |
29,571
+433
| +1% | +$7.68K |
|
|
ILG
3540
CALL
DELISTED
ILG, Inc Common Stock
ILG
| $519K | ﹤0.01% |
19,400
-49,700
| -72% | -$1.32M |
|
3541
Sensient Technologies
SXT
$5.47B
| $518K | ﹤0.01% |
6,725
-10,119
| -60% | -$766K |
|
|
VISN
3542
Vistance Networks Inc
VISN
$2.28B
| $517K | ﹤0.01% |
15,577
-52,976
| -77% | -$1.81M |
|
3543
Manitowoc
MTW
$510M
| $517K | ﹤0.01% |
14,359
+2,017
| +16% | +$58.6K |
|
|
SA
3544
Seabridge Gold
SA
$3.12B
| $517K | ﹤0.01% |
42,347
+24,901
| +143% | +$288K |
|
|
3545
CALL
Gold Fields
GFI
$33.4B
| $515K | ﹤0.01% |
119,400
+51,100
| +75% | +$209K |
|
|
EMES
3546
PUT
DELISTED
Emerge Energy Services LP
EMES
| $515K | ﹤0.01% |
62,500
+2,000
| +3% | +$14.7K |
|
3547
PUT
H&R Block
HRB
$5.82B
| $514K | ﹤0.01% |
19,400
-14,600
| -43% | -$424K |
|
3548
Prosperity Bancshares
PB
$8.88B
| $514K | ﹤0.01% |
7,806
-95,743
| -92% | -$6M |
|
3549
CALL
Xylem
XYL
$28.2B
| $514K | ﹤0.01% |
8,200
-8,300
| -50% | -$496K |
|
|
SGMO
3550
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $512K | ﹤0.01% |
34,100
-29,000
| -46% | -$321K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.